In a recent Morning Briefing, Kaiser Health News (KHN) touched on recent health policy coverage from major news organizations, including the following stories: The New York Times recently profiled Aledade, a McKesson Ventures portfolio company, and the progress it has made at two primary care...
Swisslog Healthcare has announced that it will be investing significantly in PipelineRx. The two companies will be using their new partnership to improve hospital workflow efficiency and to provide patients with a better experience. The two companies will be improving digitization options for their clients to...
As the promises of genomics are starting to come to fruition, hospitals need to start preparing for the changes genomics will bring to health care. Thousands of Americans are being treated, or are changing their treatments, based on information from genome testing. The cost of whole...
Bethesda, Maryland-based Aledade, a value-based care network with 15 accountable care organizations (ACOs), is planning to form a primary care physician-led ACO in New Jersey in January 2018. Aledade will collaborate with the New Jersey Academy of Family Physicians for the ACO. As part of the...
Binary Foundation and Kyruus will be partnering to help healthcare organizations increase their online patient acquisition and the general patient experience. The partnership will integrate Kyruus’s ProviderMatch™ for Consumers, a web-based search and scheduling solution that can be embedded directly onto healthcare groups’ websites, and Binary’s...
It's no surprise that the healthcare sector is full of executives with health-related backgrounds. A 2011 study of CEOs at the best hospitals in the US found that most CEOs specialized in cardiovascular care, cancer, and digestive disorders. And according to the Harvard Business Review,...
Amazon has started a skunkworks lab headquartered in the company’s Seattle home base to work on healthcare technology innovations. Dubbed 1492, the lab is focusing on both hardware and software projects, including pulling data from existing electronic medical records and telemedicine projects. The idea is...
In March 2017, Amazon invested in GRAIL, a health startup that is researching deep sequencing technology to discover early signs of cancer in the blood. At the time, it was unclear as to why Amazon would be interested in a company like this, given the...
Verily, Alphabet’s life sciences spinoff, has invested in Bay Area biotech startup Freenome in a $65 million Series A round. Freenome’s work revolves around detecting early-stage cancer. As part of the investment, Verily constructed a new lab for the company. Freenome’s 40 employees have already moved to...
In a recent article for the Financial Times, David Crow details how cancer has deeply affected his family: five family members, including his mother, have died of cancer. Hereditary cancer tests like those offered by Myriad Genetics make it possible for individuals like David to analyze...